A Cochrane systematic review finds that pharmaceutical industry “perks”—including free meals, and related incentives—can influence doctors’ prescribing behaviour. The review reports a dose-response pattern, meaning that the more prescriptions are written for certain drugs, the greater the level or frequency of perks described in the evidence.
Across outlets, the reported analysis centres on large-scale prescribing data linked to marketing activities. The review examines millions of doctors’ prescribing practices and assesses how visits from pharmaceutical sales representatives and covered travel relate to changes in prescribing. Multiple sources describe the findings as showing “heavy” or direct influence, while also characterising the relationship as measurable across different levels of engagement.
The outlets broadly agree on what the review investigates—how industry marketing activities correlate with prescribing—and what it concludes—an association between incentives and prescribing outcomes. They differ mainly in emphasis, with some headlines focusing on the idea of “no free lunch” and others highlighting the dose-response aspect.
